North America Apixaban Prices Movement Q2:

Apixaban Prices in USA:

During the second quarter of 2025, Apixaban price Trend in the USA reached 44,617 USD/MT in June. Prices followed a steady upward trajectory, supported by consistent demand for cardiovascular and stroke prevention medications. Rising API production and regulatory compliance costs contributed to the increase. Although generic alternatives helped limit sharp price spikes, stable domestic consumption and efficient supply chain operations maintained firm pricing throughout the quarter.

Get the Real-Time Prices Analysis: https://www.imarcgroup.com/apixaban-pricing-report/requestsample

Note: The analysis can be tailored to align with the customer's specific needs.

APAC Apixaban Prices Movement Q2:

Apixaban Prices in China:

In the second quarter of 2025, apixaban prices in China stood at 24,295 USD/MT in June, continuing their upward movement from previous quarters. Strong demand from the cardiovascular drug segment and steady API procurement reinforced price firmness. Limited competition among major domestic manufacturers sustained market stability, while rising fermentation input costs added mild upward pressure on production and pricing.

Apixaban Prices in India:

In the second quarter of 2025, apixaban prices in India were recorded at 30,369 USD/MT in June. The market displayed moderate firmness, supported by steady demand from hospitals and specialty clinics treating cardiovascular diseases. Domestic manufacturers, along with Chinese API suppliers, maintained stable supply conditions. Minor currency fluctuations and rising formulation expenses added slight upward pressure to the overall pricing trend.

Apixaban Prices in Korea:

During the second quarter of 2025, apixaban prices in South Korea reached 43,946 USD/MT in June. Prices remained stable to slightly firm amid consistent demand from the country’s robust healthcare system. While the introduction of generics created mild competition, reliance on imported APIs and growing therapeutic applications kept prices steady. Balanced supply and sustained healthcare utilization ensured pricing resilience throughout the quarter.

Regional Analysis: The price analysis can be extended to provide detailed Apixaban price information for the following list of countries.

China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.

Europe Apixaban Prices Movement Q2:

Apixaban Prices in Germany:

During the second quarter of 2025, apixaban prices in Germany reached 55,269 USD/MT in June, maintaining relative stability. Strong demand within Germany’s advanced healthcare network and restricted patent-controlled supply contributed to price resilience. Elevated API production costs and delays in generic market entries supported firm pricing, while consistent procurement across hospital and retail channels kept market volatility low.

Regional Analysis: The price analysis can be expanded to include detailed Apixaban price data for a wide range of European countries, such as Germany, France, the United Kingdom, Italy, Spain, Russia, Turkey, the Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, the Czech Republic, Portugal, and Greece, along with other European nations.

Purchase Options: https://www.imarcgroup.com/checkout?id=22910&method=1925

• Biannual Updates: For 2 Deliverables, Billed Annually
• Quarterly Updates: For 4 Deliverables, Billed Annually
• Monthly Updates: For 12 Deliverables, Billed Annually

We Also Provide News and Historical Data of Apixaban

• Historical Data: Comprehensive historical pricing and market trends.
• Quarterly Analysis: Detailed insights into price fluctuations and market dynamics.
• Regional and Global Data: Coverage of key markets and their performance.
• Forecast Comparisons: Historical data paired with future market projections.
• Customizable Reports: Tailored analysis to meet specific business needs.

Factors Affecting Apixaban Prices:

Demand-Side Factors:

• Strong demand from cardiovascular and stroke prevention therapies.
• Expanding therapeutic approvals supporting wider usage.
• Steady healthcare utilization in hospitals and specialty clinics.

Supply-Side Factors:

• Dependence on imported APIs and raw materials.
• Rising API production and formulation costs.
• Limited competition in some regions, though generics added modest pressure.

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=22910&flag=C

Key Coverage:

• Market Analysis
• Market Breakup by Region
• Demand Supply Analysis by Type
• Demand Supply Analysis by Application
• Demand Supply Analysis of Raw Materials
• Price Analysis
  • Spot Prices by Major Ports
  • Price Breakup
  • Price Trends by Region
  • Factors influencing the Price Trends
• Market Drivers, Restraints, and Opportunities
• Competitive Landscape
• Recent Developments
• Global Event Analysis

How IMARC Pricing Database Can Help

The latest IMARC Group study, “Apixaban Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data 2025 Edition,” presents a detailed analysis of Apixaban price trend, offering key insights into global Apixaban market dynamics. This report includes comprehensive price charts, which trace historical data and highlights major shifts in the market.

The analysis delves into the factors driving these trends, including raw material costs, production fluctuations, and geopolitical influences. Moreover, the report examines Apixaban demand, illustrating how consumer behaviour and industrial needs affect overall market dynamics. By exploring the intricate relationship between supply and demand, the prices report uncovers critical factors influencing current and future prices.

About Us:

IMARC Group is a global management consulting firm that provides a comprehensive suite of services to support market entry and expansion efforts. The company offers detailed market assessments, feasibility studies, regulatory approvals and licensing support, and pricing analysis, including spot pricing and regional price trends. Its expertise spans demand-supply analysis alongside regional insights covering Asia-Pacific, Europe, North America, Latin America, and the Middle East and Africa. IMARC also specializes in competitive landscape evaluations, profiling key market players, and conducting research into market drivers, restraints, and opportunities. IMARC’s data-driven approach helps businesses navigate complex markets with precision and confidence.

Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-631-791-1145